The Relationship Between Osteoporosis and Sarcopenia Parameters in Postmenopausal Women Under 60

This cross-sectional study will include postmenopausal women under the age of 60 who visited the Physical Medicine and Rehabilitation outpatient clinic at Beylikdüzü State Hospital between June 25 and July 25, 2025. Participants must have undergone a bone mineral density (BMD) assessment within the past six months using Dual X-ray Absorptiometry (DXA). Both osteoporotic and non-osteoporotic patients will be enrolled. Sociodemographic data such as age, height, weight, and BMI will be recorded. Femoral neck and L1-L4 T-scores and BMD values will be obtained from existing DXA results. Information on osteoporosis treatment, presence of fecal incontinence, constipation, and medication use will be collected. In the second phase, sarcopenia will be assessed according to EWGSOP2 criteria using bioelectrical impedance analysis for skeletal muscle mass, handgrip strength, and the five-time sit-to-stand test. Differences between the osteoporotic and non-osteoporotic groups will be analyzed.

NCT Number	NCT07045012
Lead Sponsor	Beylikduzu State Hospital
Conditions	Osteoporosis
Enrollment	52 participants
Start Date	2025-06-25
Primary Completion	2025-07-25 (estimated)
Study Completion	2025-07-25 (estimated)
Updated on ClinicalTrials.gov	2025-07-01